Skip to main content

Table 3 Basic demographic data of patients with hepatocellular carcinoma of different BCLC stages between surgical resection and non-surgical resection

From: Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis

Variable

BCLC stage 0 (N = 66)

BCLC stage A (N = 865)

BCLC stage B (N = 575)

BCLC stage C (N = 810)

SR (N = 27)

Non-SR (n = 39)

P value

SR

(N = 289)

Non-SR (N = 576)

P value

SR

(N = 164)

Non-SR (N = 411)

P value

SR (N = 58)

Non-SR (N = 752)

P value

Male

21 (77.8)

25 (64.1)

0.235

225 (77.9)

380 (66)

0.001

135 (82.3)

302 (73.5)

0.025

45 (77.6)

615 (81.8)

0.428

Age (years)

55 (23–83)

66 (24–85)

0.001

59 (29–90)

63 (28–92)

0.0001

63 (30–88)

64 (30–91)

0.095

60 (25–87)

61 (19–99)

0.597

Smoking

10 (37)

18 (46.2)

0.461

92 (31.8)

224 (38.9)

0.042

71 (43.3)

161 (39.2)

0.363

20 (34.5)

353 (46.9)

0.067

Alcohol use

8 (29.6)

14 (35.9)

0.595

84 (29.1)

199 (34.5)

0.105

67 (40.9)

151 (36.7)

0.359

17 (29.3)

328 (43.6)

0.034

HBV positive

23 (85.2)

21 (53.8)

0.008

197 (68.2)

402 (69.8)

0.625

111 (67.7)

303 (73.7)

0.145

41 (70.7)

560 (74.5)

0.526

HCV positive

5 (18.5)

9 (23.1)

0.656

81 (28)

172 (29.9)

0.576

41 (25)

131 (31.9)

0.104

18 (31)

239 (31.8)

0.906

Cirrhosis

20 (74.1)

23 (59)

0.206

172 (59.5)

339 (58.9)

0.852

95 (57.9)

239 (58.2)

0.961

28 (48.3)

479 (63.7)

0.019

Child-Pugh class A

20 (74.1)

23 (59)

0.206

87 (30.1)

190 (33.0)

0.212

60 (36.6)

165 (40.1)

0.327

20 (34.5)

289 (38.4)

0.109

Tumor size (cm)

1.7 (1.0–2.0)

1.6 (1.0–2.0)

0.546

3.1 (1.0–5.0)

2.7 (1.0–5.0)

< 0.001

8.1 (1.2–21)

7.3 (1.2–21)

0.002

9.5 (1.2–27)

9.4 (1.2–27)

0.850

Tumor number

1 (1–1)

1 (1–1)

1.000

1.4 (1–3)

1.5 (1–3)

0.089

2.1 (1–5)

2.6 (1–11)

0.003

2.7 (1–11)

2.7 (1–11)

0.890

Mortality

14 (51.9)

23 (58.9)

0.566

193 (66.80

279 (48.4)

0.0001

158 (60.1)

293 (48.7)

0.002

28 (48.3)

452 (60.1)

0.077

Median OS (months)

71 (30–96)

44 (8–81)

 

53 (3–88)

41 (1–96)

 

41 (4–84)

24 (1–76)

 

38 (6–79)

16 (1–66)

 
  1. BCLC stage: Barcelona clinic liver cancer; SR: Surgical resection; HR: Hazard ratio; CI: Conference incidence; HBV: Hepatitis B virus; HCV: Hepatitis C virus; OS: Overall survival; Number (%); Mean or Median (range)